The purpose of this study is to assess the safety and effectiveness of 3 doses of the investigational drug as compared to a placebo after 12 weeks of treatment in subjects with treatment-resistant hypertension.
Participants must be an adult at least 18 years of age with high blood pressure and has been unable to reach their goal blood pressure numbers with their current treatments. Other criteria also apply but will be addressed later in a qualifying questionnaire.
Duration: Up to 6 months
Number of visits to AMR Lexington: 10 plus 2 phone call visits
Compensation is available for time and travel.
If you are interested in participating in this study, please fill out the form below. This will help us determine if you meet some of the initial criteria necessary to participate. We will contact you within 48 hours to follow up and clarify any questions that you, or we, may have. The information you provide is entered in our secure, password protected database which can only be accessed by authorized AMR Lexington personnel, unless given your permission or except as required by law. The provided information will only be used to contact you to tell you more about this and any future study. Your contact information will remain within our database indefinitely unless otherwise requested.